Boots to begin Prescribing Medical Cannabis in the UK

Boots is set to become the first UK high street pharmacy to prescribe medical cannabis. Here’s how its new service will work.

Boots to begin Prescribing Medical Cannabis in the UK f

"This can have a significant impact on everyday life"

Boots is set to become the first UK high street pharmacy to prescribe medical cannabis, launching a new online service for patients aged 25 and over with eligible health conditions.

The pharmacy chain said its SureLeaf service will initially be available to people living with conditions including chronic pain, anxiety and insomnia, offering access to specialist assessments and potential treatment with cannabis-based medicines.

The launch also includes a collaborative research programme with the University of Nottingham, which will examine patient outcomes, prescribing practices and experiences of using medical cannabis to treat chronic pain.

Patients interested in the service will initially be invited to complete an online assessment.

Their suitability will then be reviewed by a clinical team before eligible individuals are invited to attend a video consultation with a specialist consultant.

Boots said any prescription would be “independently reviewed by a multidisciplinary clinical team that includes a second, independent consultant, before treatment begins”.

Patients must also have tried conventional treatments without success before they can be considered for medical cannabis. Those who receive a prescription will be subject to regular reviews to monitor their treatment and progress.

Jamie Kerruish, chief healthcare officer at Boots, said: “Millions of people live with ongoing pain and, for some, conventional treatments do not provide adequate symptom relief.

“This can have a significant impact on everyday life, from working and sleeping well to spending time with family and doing the things they enjoy.

“Ultimately, it’s about helping people explore appropriate options that could help them better manage their symptoms and improve their quality of life.”

Dr David Gwynne, medical director of Boots’ online service, said:

“Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis.

“SureLeaf has, therefore, been designed with strong clinical safeguards and specialist oversight at every stage, so treatment is only considered for patients where it is clinically appropriate.

“Our priority is to ensure patients receive responsible, clinically led care, from their initial specialist assessment through to ongoing monitoring and review once treatment begins.”

The move comes eight years after cannabis-derived medicines were legalised in the UK in 2018, following a high-profile campaign by the family of Billy Caldwell, a young boy from Northern Ireland with severe epilepsy.

His mother, Charlotte Caldwell, had travelled to Canada to obtain cannabis oil to treat his condition, but the medication was seized by customs officials at Heathrow Airport on her return to the UK.

The case prompted widespread criticism of existing cannabis laws and contributed to the decision to change the regulations.

Despite the legal change, access to medical cannabis on the NHS remains limited.

It can be prescribed for certain rare forms of epilepsy, chemotherapy-related nausea and vomiting when other treatments have not worked, and muscle stiffness and spasms associated with multiple sclerosis.

Private clinics, meanwhile, have expanded access to cannabis-based medicines, prescribing them for conditions including chronic pain and various psychiatric and neurological disorders.

There have also been growing questions about how effective medical cannabis is for different health conditions, with researchers warning that the evidence supporting some of its uses remains limited.

A review published in March 2026 by researchers from universities in Sydney, Brisbane and Melbourne in Australia, and the University of Bath in England, found “very little evidence” that cannabis was effective in treating common mental health conditions and disorders, including anxiety, anorexia nervosa, psychotic disorders, post-traumatic stress disorder and opioid use disorder.

However, the researchers identified some evidence that cannabis-based medicines could help reduce dependence on cannabis, relieve symptoms of Tourette syndrome and improve sleep for people experiencing insomnia.

Lead Editor Dhiren is our news and content editor who loves all things football. He also has a passion for gaming and watching films. His motto is to "Live life one day at a time".





  • Play DESIblitz Games
  • What's New

    MORE

    "Quoted"

  • Polls

    Which is your most favourite Naan?

    View Results

    Loading ...
  • Share to...